Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, & Regulatory Capture
Key insights
Media referenced
- Paul Janssen YouTube interviews on regulatory capture in pharma - other - Cited as evidence that FDA safety-only focus (risk without weighing benefit) slowed and raised the cost of drug development; used as an analogy for how AI regulation could go the same way.
Companies
- Anthropic - Cited as one of three companies (with OpenAI and SpaceX) that went from near-zero to a trillion dollars in market cap in roughly five years.
- OpenAI - Second of the three trillion-dollar-in-five-years companies; also named as a company that should never sell.
- SpaceX - Third of the trillion-dollar-in-five-years companies; contrasted with the ~15-20 year arcs of prior giants like Google.
- Google - Reference point for how long (15-20 years) it used to take to build a trillion-dollar company; also the subject of an old joke about how few employees actually drive the company's results.
- Harvey - Legal AI company used as an example of investors still pricing AI value on a per-seat/per-lawyer basis instead of outcome-based value.
- Open Evidence - Named among founders who went after markets the frontier labs could also target, illustrating aggressive rather than niche positioning.
- Decagon - Named alongside Sierra and Open Evidence as founders competing in markets that could be in a frontier lab's roadmap.
- Sierra - Same point as above, cited as an example of a company entering a market a lab could also pursue.
- Cognition - Cited as a portfolio company that entered a big, contestable market roughly two years ago.
- Cursor - Referenced in the discussion of financing structure and matching capital access to competitive position.
- Minecraft - Cited as an early real example of a tiny team (five to ten people) producing a multi-billion-dollar outcome, predating today's AI-driven one-person-company narrative.
- Microsoft - The acquirer of Minecraft, referenced in the same point about small teams and outsized outcomes.
- Tesla - Mentioned as part of the hardware/energy corridor shift toward Texas.
- Anduril - Cited as part of the growing hardware corridor originally centered around El Segundo before shifting toward Texas.
- Conviction - Sarah Guo's venture fund; its grant program (embed.conviction.com) is promoted mid-episode, offering $250,000 on an uncapped note plus compute and partner services.
- Chai Discovery - Named as one of Conviction's grant program cohort companies.
- Listen Labs - Named as one of Conviction's grant program cohort companies.
- Physical Intelligence - Named as one of Conviction's grant program cohort companies.
- Base10 - Named as one of the partners providing compute and services to Conviction's grant program.
- GE - Cited as a likely destination for engineering talent displaced from Google/Meta-tier companies as AI reshapes staffing.
- PG&E - Same point, cited as an 'old school' enterprise that could absorb displaced big-tech engineering talent.
- Hershey's - Same point, another example of a traditional enterprise that could newly access top engineering talent via AI-driven displacement.
Techniques and frameworks
- Punctuated equilibrium (evolution analogy applied to tech waves) - Used to explain why trillion-dollar-company formation happens in bursts (social, SaaS, crypto, AI) followed by consolidation rather than as a smooth continuous process.
- Return on invested tokens (ROIT) - Proposed framework for deciding which projects and people should receive outsized shares of a compute/token budget, treating tokens as a scarce resource to be allocated for maximum return rather than distributed evenly.
- Pre-scheduled, non-emotional exit-consideration board meeting - A Ben Horowitz-derived practice: put 'should we consider exiting in the next six months' on the board calendar in advance so the question gets asked rationally rather than only in a crisis or under investor/founder pressure.
Summary
Sarah Guo and Elad Gil, the two hosts of No Priors, use this episode as a two-hander conversation (no outside guest) to work through how many more trillion-dollar companies AI will actually produce, and conclude the number is small. Three companies - Anthropic, OpenAI, and SpaceX - went from near-zero to a trillion dollars in roughly five years, compared to the usual 15-20 year climb of prior giants like Google. They frame this less as a permanent new normal and more as a punctuated-equilibrium moment: technology waves (social, SaaS, crypto, AI) produce a burst of category-defining "consolidator" companies and then settle into a steady state. Getting to a trillion dollars requires 50-100 billion dollars of annual revenue at good margin, which only a handful of markets can plausibly deliver in the next three to five years - most "huge TAM" AI companies will land in the 20-100 billion dollar range, still enormous, but not trillion-dollar territory. A related mispricing they flag: investors say they believe AI companies can charge for outcomes rather than seats, but still underwrite deals with old per-seat SaaS math, missing how much bigger markets like coding actually are once consumption-based pricing is taken seriously.
The conversation's second thread is founder ambition and exit timing. Both hosts observe a trend line, concentrated among otherwise strong founders, of retreating into niche markets out of fear of the frontier labs rather than competing head-on and out-executing on product and distribution. On exits, they converge on a shared framework: a small set of companies (Anthropic, OpenAI) should never sell, but most companies pass through a 12-18 month window where they're worth the most they will ever be worth, and the decision to consider selling should be a pre-scheduled, unemotional board conversation (a practice credited to Ben Horowitz) rather than a reactive one. Because a year of AI-era progress compresses roughly three to four years of normal-cycle progress, that check-in cadence has tightened from roughly once a year to roughly every six months. The real cost of staying too long in an underperforming, overcapitalized company isn't just capital - it's a founder's most productive years, illustrated by 2020-2021-vintage founders still running companies years later that aren't working, having been locked up through the entire AI transition.
A third thread digs into compute and research talent economics. Physical compute scarcity, not algorithmic limits, is described as the real binding constraint on AI progress, and because compute is allocated roughly pro rata across the ecosystem, it effectively enforces an oligopoly and closer competitive parity among frontier labs than would otherwise exist. Within labs, a power-law pattern applies: a few dozen researchers drive the large majority of results (a pattern the hosts compare to breast cancer research, subfields of math and physics, and startup founders generally), pushing some labs to raise hiring bars sharply since the real cost of a researcher is the compute allocated to them. This motivates a "return on invested tokens" (ROIT) framing for deciding who gets outsized compute budgets, and a related, more speculative prediction: as AI reduces need for less-productive engineers at top-tier tech companies, that talent will likely flow toward traditional non-tech enterprises (GE, PG&E, Hershey's are named) that never had the brand to recruit top engineers before.
The hosts also discuss the psychological toll of believing recursive self-improvement (RSI) is roughly 18 months away - a prediction that has recurred on an 18-month cycle for about five years, making it a weak predictor even as it drives real burnout-adjacent behavior, including researchers reportedly asking whether they should get married given uncertainty about the world in 18 months. The episode closes on regulatory capture, tying together a California case study (a proposed billionaire tax that would force asset sales for founders of 10-billion-dollar-plus companies, plus talk of a companion exit tax) with historical analogies to pharma and nuclear energy. Paul Janssen's account of FDA history is cited as an example of regulation that weighed safety without weighing benefit, slowing drug development for decades; France's 70 percent nuclear power generation with essentially no major accidents, versus the US's 18 percent and 40 years without a new reactor, is offered as evidence that a 1970s safety lobby - not the technology itself - killed abundant clean energy in America. The hosts argue AI regulation risks the same pattern if downside risk (e.g., an email getting hacked) is weighed without also weighing upside (e.g., faster healthcare breakthroughs), and close with a case for keeping AI lightly regulated relative to how heavily other industries have been regulated historically.
Notable Quotes
Note: the source transcript (podscripts ASR) carries no speaker diarization. Attribution below is inferred from context (the Conviction ad-read, greeting order, and known investing focus of each host) and should be treated as best-effort, not verified against audio.
"We had three companies roughly go from close to zero to a trillion dollars in market cap, right? ... that's unprecedented in human history. Usually it takes 20 years." - Elad Gil
"There's a handful of companies that should never ever sell, at least any time in the near term. If you're Anthropic, you shouldn't sell. If you're OpenAI, you shouldn't sell." - Elad Gil
"Your most productive years of your life are on the line right now. And you can either walk away with a good amount of money... or you can roll the dice." - Elad Gil
"The physical compute basically reinforces an oligopoly market because... it creates a ceiling on the rate of progress any single lab can get." - Sarah Guo
"We had a safety lobby in the 70s basically kill abundant clean energy for us." - Sarah Guo